What are the treatment options for molluscum contagiosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Molluscum Contagiosum

The most effective first-line treatment for bothersome molluscum contagiosum is cryotherapy with liquid nitrogen, which has a 93.3% complete response rate, or cantharidin application which is well-tolerated and effective, particularly in children. 1

Treatment Algorithm

First-Line Options:

  1. For asymptomatic, limited lesions in immunocompetent patients:

    • Observation for spontaneous resolution with monitoring for 3-6 months 1
    • Cover visible lesions with clothing/bandages to prevent spread
  2. For bothersome, extensive, or symptomatic lesions:

    • Cryotherapy with liquid nitrogen - applied every 1-2 weeks until lesions resolve 1
    • Cantharidin application - well-tolerated, especially in children 1, 2
    • 10% potassium hydroxide - comparable efficacy to cryotherapy (86.6% complete response) 1

Second-Line Options:

  • Surgical options:

    • Curettage or excision
    • Tangential scissor excision
    • Shave excision
    • Electrosurgery (for larger lesions) 1
  • Chemical treatments:

    • Trichloroacetic acid (TCA) or Bichloroacetic acid (BCA) 80%-90% - apply until white "frosting" develops 1
    • Podophyllin resin 10%-25% in compound tincture of benzoin 1

Important Considerations

Efficacy of Treatments

Treatment Efficacy Potential Complications
Cryotherapy 93.3% complete response Pain, necrosis, blistering, hyperpigmentation
Cantharidin High efficacy Minimal side effects
10% KOH 86.6% complete response Mild irritation

Special Populations

Children:

  • Avoid painful treatments in young children when possible 1
  • Cantharidin is particularly well-tolerated in children 2
  • Important note: Imiquimod is NOT recommended as randomized controlled trials have shown it is not more effective than placebo 1 and FDA labeling confirms this lack of efficacy in pediatric studies 3

Near-Eye Lesions:

  • Prompt treatment is recommended to prevent conjunctivitis 1

Immunocompromised Patients:

  • Evaluation for immunocompromised state should be considered in adults with large and multiple lesions 1

Prevention of Spread

  • Cover visible lesions with clothing or bandages
  • Maintain good hand hygiene, especially after touching lesions
  • Avoid sharing personal items like towels and clothing
  • Avoid scratching or picking at lesions to prevent autoinoculation 1

Common Pitfalls to Avoid

  1. Using imiquimod as treatment - Despite its common use, clinical studies have demonstrated it is not more effective than placebo for molluscum contagiosum 1, 3

  2. Failing to identify and treat nascent lesions - This increases recurrence risk 1

  3. Overlooking associated conditions - Patients with atopic dermatitis may develop more widespread involvement 4

  4. Ignoring prevention measures - Essential to provide guidance on preventing spread through avoiding touching lesions and intimate contact until resolution 1

  5. Using painful treatments in young children - Can cause unnecessary trauma when less painful options are available 1

The recent FDA approval of YCANTH™ (cantharidin 0.7%) topical solution provides a standardized formulation for treating molluscum contagiosum in children (≥2 years) and adults, with demonstrated efficacy in phase-3 trials 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.